Home/Filings/4/0000950170-24-103807
4//SEC Filing

Huizenga Theodore Alan 4

Accession 0000950170-24-103807

CIK 0001515673other

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 11:50 AM ET

Size

5.0 KB

Accession

0000950170-24-103807

Insider Transaction Report

Form 4
Period: 2024-09-03
Huizenga Theodore Alan
Controller and PAO
Transactions
  • Sale

    Common Stock

    2024-09-03$56.19/sh91$5,11341,551 total
Footnotes (3)
  • [F1]Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
  • [F2]Includes 276 shares acquired under the Company's Amended and Restated 2014 Employee Stock Purchase Plan on April 30, 2024
  • [F3]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Documents

1 file

Issuer

Ultragenyx Pharmaceutical Inc.

CIK 0001515673

Entity typeother

Related Parties

1
  • filerCIK 0001603347

Filing Metadata

Form type
4
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 11:50 AM ET
Size
5.0 KB